이뮨온시아, ‘PD-L1 억제 면역항암제’ 2상 승인
[Korean News] http://www.biospectator.com/view/news_view.php?varAtcId=10394
Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody)
[Korean News] http://www.bosa.co.kr/news/articleView.html?idxno=2125721 [English News] https://www.prnewswire.com/news-releases/samsung-biologics-and-immuneoncia-therapeutics-inc-development-and-manufacturing-agreement-accomplishes-ind-clearance-of-imc-002-anti-cd47-antibody-301045318.html
이뮨온시아,면역항암제 후보물질 임상 계획 미국 FDA 제출
[Korean News] http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241681
KDDF, ‘차이나 서밋’ 참여해 국내 투자 유치 도모
[Korean News] http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237700
이뮨온시아, 면역함암제 임상1상 결과 공개
[Korean News] http://health.chosun.com/news/dailynews_view.jsp?mn_idx=332960
사노피 출신 대표가 이끌고, 유한이 선택한 ‘그 회사’
[Korean News] http://www.hitnews.co.kr/news/articleView.html?idxno=11928